9am.health Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • 9am.health's estimated annual revenue is currently $10.8M per year.(i)
  • 9am.health's estimated revenue per employee is $216,000

Employee Data

  • 9am.health has 50 Employees.(i)
  • 9am.health grew their employee count by 28% last year.

9am.health's People

NameTitleEmail/Phone
1
Co-Founder & Co-CEOReveal Email/Phone
2
Co-Founder & COOReveal Email/Phone
3
Co-Founder & Co-CEOReveal Email/Phone
4
Co-Founder & CTOReveal Email/Phone
5
CFOReveal Email/Phone
6
Head Health Plan PartnershipsReveal Email/Phone
7
Head CommunicationReveal Email/Phone
8
VP MarketingReveal Email/Phone
9
VP SalesReveal Email/Phone
10
VP Pharmacy OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$354.2M9376%N/AN/A
#2
$4.5M24-14%N/AN/A
#3
$25.9M96-14%N/AN/A
#4
$18M74-16%N/AN/A
#5
$10.8M509%N/AN/A
#6
$32.9M1228%N/AN/A
#7
$187.3M5559%N/AN/A
#8
$417.7M110522%N/AN/A
#9
$25.9M9628%N/AN/A
#10
$108.7M3228%N/AN/A
Add Company

What Is 9am.health?

keywords:N/A

N/A

Total Funding

50

Number of Employees

$10.8M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

9am.health News

2022-04-19 - Why Glen Tullman is backing virtual diabetes clinic 9am.health

To fuel its ambitious aim of transforming diabetes care and support the company's rapid growth, 9am.health has raised $20 million in funding...

2022-04-17 - 9am.health Raises $16 Million Series A To Build a ...

9am.health is a virtual diabetes clinic providing affordable medications, labs, and personalized, compassionate medical care for people living...

2022-04-17 - 9am.Health Nabs $16M to Expand Virtual Diabetes Clinic ...

9am.health provides a subscription-based direct-to-consumer diabetes treatment platform that includes home delivery of Rx for prediabetes and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.8M500%N/A
#2
$9.8M50-15%N/A
#3
$3.5M500%N/A
#4
$11M500%N/A
#5
$7.2M504%N/A